Marketresearchnews

Tuesday, 4 May 2021

Global Peripheral Neuropathy Market Industry Production and Demand, Competition News and Trends Forecasts to 2027

Market Highlights

According to MRFR analysis, Peripheral Neuropathy Market is expected to register a CAGR of 3.9% during the forecast period of 2019 to 2025 and is expected to reach USD 292.40 Million by 2025.

Peripheral neuropathy develops when nerves in the body’s extremities, such as the hands, feet, and arms, are damaged. The symptoms depend on which nerves are affected.

The growth of the global peripheral neuropathy market is driven by various factors, such as increasing chemotherapy treatments for cancer and growing awareness about peripheral neuropathy. Additionally, rising innovations in the field of peripheral neuropathy by top players are also driving the market. However, stringent government regulations are projected to hamper the growth of the global peripheral neuropathy market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8485

Several market players currently dominate the global peripheral neuropathy market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For example, in June 2015, Spinifex Pharmaceuticals acquired by Novartis. The acquisition was centered on Spinifex’s EMA401, a new drug that could offer relief from chronic neuropathic pain. This acquisition helps Novartis to be a prominent player in the peripheral neuropathy market by expanding the market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the rising per capita healthcare expenditure. The peripheral neuropathy market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European peripheral neuropathy market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The peripheral neuropathy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising geriatric population and the growing prevalence of diabetes, Asia-Pacific is expected to be the fastest-growing. The peripheral neuropathy market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Peripheral Neuropathy Market has been segmented based on type, treatment, and end user.

The market, based on type, has been divided into diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), idiopathic peripheral neuropathy, and HIV/AIDS-associated peripheral neuropathy.

The diabetic peripheral neuropathy (DPN)segment is likely to be the largest during the review period due to their increasing prevalence of diabetic peripheral neuropathy in youth with diabetes.

The chemotherapy-induced peripheral neuropathy (CIPN) segment is predicted to be the fastest-growing due to increasing chemotherapy for the treatments of cancer patients. Many market players come up with different treatment methods and devices with advanced technologies. For instance, in June 2019, RxFunction launched sensory prosthesis for people with peripheral neuropathy.

The global peripheral neuropathy market has been segregated, on the basis of treatment, into pharmacological therapies, non-pharmacological therapies, and others.

The pharmacological therapies segment is expected to hold the majority share of the market owing to the pharmacological therapies are primary in the treatment of peripheral neuropathy. The non-pharmacological therapies segment is expected to be the fastest-growing due to the as non-pharmacological therapies are used along with other treatment options for neurotherapy.

The end users of the market are hospitals and clinics, ambulatory centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market due to the rising awareness about advanced treatments available in the hospitals and expertise. The ambulatory centers segment is expected to be the fastest growing owing to the availability of specialized medical services and advanced medical technology

Key Players

Some of the key players in the Global Peripheral Neuropathy Market are Abbott Laboratories (US), Bristol Myers Squibb (US), Novartis AG (UK), Eli Lilly and Company (US), Pfizer Inc (US), GlaxoSmithKline plc (UK), Merck and Co. Inc. (US), Cipla Limited (India), Lupin Limited (India), Dr. Reddy’s Laboratories (India), F. Hoffmann-La Roche Ltd. (UK), RxFunction, Inc. (US) among others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/peripheral-neuropathy-market-8485

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Vitiligo Treatment Market – Insights on Upcoming Trends 2027

Market Highlights

According to MRFR analysis, Vitiligo Treatment Market is expected to register a CAGR of 5.6% during the forecast period of 2019 to 2025 and was valued at USD 1.22 Billion in 2018.

Vitiligo is a skin disorder that causes white patches to appear on the skin. These patches occur because the melanocytes are destroyed, leaving areas of skin with no pigment at all. It can affect any skin part of the body.

The growth of the global vitiligo treatment market is driven by various factors such as emerging therapies for skin disorders, increasing healthcare expenditure, lifestyle changes. However, the lack of skilled professionals is expected to curb the growth of the global vitiligo treatment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8442

Several market players currently dominate the global vitiligo treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, Incyte Corporation reported positive results from the study of ruxolitinib cream which is in phase 2. This topical cream is suggested for vitiligo treatment.

Segmentation

The global vitiligo treatment market has been segmented based on type, treatment type, and end-user.

The market, based on type, has been divided into non-segmental and segmental. On the basis of treatment type, the market has been segmented into therapy, surgery, medication, and others. The therapy is further segmented into light therapy and depigmentation. The surgery is segmented into skin grafting, blister grafting, and micro-pigmentation. The medication is segmented into topical corticosteroids and immunosuppressive drugs.

The end-user segments of the market consist of hospitals, aesthetic clinics, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.

Key Players

Some of the Key Players in the Global Vitiligo Treatment Market are Bausch Health Companies Inc. (Laval, Quebec), STRATA Skin Sciences (Horsham, PA), Reddy’s Laboratories Ltd. (India), Allergan, Inc. (Dublin, Coolock), Clinuvel Pharmaceuticals Limited (Melbourne, Victoria), Astellas Pharma Inc. (Northbrook, IL), Novartis AG (Basel, Basel-Stadt), Eli Lilly Company (Indianapolis, Indiana), Incyte Corporation (Wilmington, Delaware), AstraZeneca AB (Cambridge, Cambridgeshire), Epizyme, Inc. (Cambridge, MA), Pfizer Inc. (New York),and Baxter International Inc. (Deerfield, Illinois)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to be the largest market owing to the significant investments by healthcare and medical regulatory bodies in vitiligo treatment to deliver quick medical aid to patients. The vitiligo treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European vitiligo treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The vitiligo treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing number of patients with vitiligo and increasing mergers & acquisitions among the market players are boosting the Asia-Pacific region. The vitiligo treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/vitiligo-treatment-market-8442

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Monday, 3 May 2021

Flexible Spinal Implants Market Analysis and Value Forecast Snapshot by End-use Industry 2020-2027

Market Scenario:

Technological advancements in spine implants, increasing aging and obese population, rising cases of spine deformities, demand for minimally invasive spine surgery, growth in the number of hospitals offering spinal surgeries are fueling the growth of global flexible spinal implants market. The market restraints are stringent product approval process, uncertain reimbursement scenario, high cost of treatment procedures, concerns about safety of advanced products etc.

Considering all these factors the flexible spinal implants market is expected to reach 4 billion USD by the end of 2023, this market is projected to growing at a CAGR of ~ 13.2 % during 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

Key Players of Global Flexible Spinal Implants Market:

Key players profiled in the report are Paradigm Spine LLC, Medtronic plc., Abbott Spine, Inc., Raymedica, K2M Group Holdings, Stryker Corporation, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Alphatec Holdings, Inc., NuVasive, Inc., Orthofix International N.V., and others.
Intended Audience

Global flexible spinal implants solution providers, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities

Market Segments:

The global flexible spinal implants market is segmented on the basis of type and applications. Based on type, the market has been segmented as rods, hooks, pedicle screws, plates, cages and other. Based on the applications, the market has been segmented as thoracic, lumbar, cervical, artificial discs and other.

Study objectives:

To provide a detailed analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global flexible spinal implants market.
To provide insights about factors affecting the market growth.
To analyze the global flexible spinal implants market based on various factors – price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – Americas, Europe, Asia Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospects.
To provide country level analysis of the market’s segments which includes by type and applications.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new disease developments along with research and developments that are currently taking place in the global flexible spinal implants markets.

Regional Aanalysis:

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East and Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/flexible-spinal-implants-market-3755

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Research report covers the Muscle Stimulator Market share and Growth, 2020-2027

Market Scenario:

The muscle stimulators use electric current to elicit contraction in muscles or nerves. The electric signal has intensity and frequency which mimics the nerve signal system. The market for muscle stimulator is rising due to drivers such as increasing popularity of sports and increased demand for fitness products, increasing healthcare expenditure and rising affordability of muscle stimulators, demand for non-invasive technology devices and growing preference for muscle stimulators among physiotherapists etc. The rising population of geriatrics is also a strong stimulant. According to the world health organization by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

The world health organization also estimates that today, 125 million people are aged 80 years or older. Thus the huge rise in geriatrics around the globe, will drive the market due to greater frequency of muscle ailments in the geriatrics population. There has been increasing incidence of muscle diseases and disorders such as low back pain, spinal injuries etc. are driving the market. The rise of risk factors such as growing prevalence of diabetes, increasing incidence of accident injuries, occupational injuries etc. is driving the growth of these diseases.

The restraints include competition from alternative therapies such as acupuncture, yoga, and aroma therapy etc., lack of usage guidelines and safety concerns and regulatory uncertainties in the US.

Considering all these factors the market for muscle stimulator is expected to reach $ 768.3 million by the end of 2023, this market is projected to growing at a CAGR of ~ 6.1 % during 2017-2023.
Study objectives:

To provide detail analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global muscle stimulator market.
To provide insights about factors affecting the market growth.
To analyze the global muscle stimulator market based on various factors – price analysis, supply chain analysis, Porters Five Force Analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – Americas, Europe, Asia-Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by products, and by application.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new disease developments along with research and developments currently taking place in the global muscle stimulator market.

Key players of Global Muscle stimulator Market:

Key players profiled in the report are DJO Global, Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix, Inc., OMRON Corporation, Tone-A-Matic and others.

Segments:

The global muscle stimulator market is segmented on the basis of products. Based on the products, the market has been segmented as transcutaneous electrical nerve stimulator, burst mode alternating current, neuromuscular electric stimulation, and interferential current. Based on the application, the market has been segmented as pain management, neurological and movement disorder management and musculoskeletal disorder management.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/muscle-stimulator-market-779

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Acute Myeloid Leukemia Treatment Market Is Seeing Explosive Growth by Future Industry Winners: Forecast, 2020-2027

Market Scenario

The Acute Myeloid Leukemia Treatment market is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approximately 5.3 % during 2017-2023.

Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3223

The market driving factors are the rising number of stem cell banks and the increase in genetic profiling of cancer genes which is increasing the understanding of AML. The increasing interest and expenditure as well as grants for stem cell research will lead to future growth due to their high potential.

Key players of Global Acute Myeloid Leukemia Treatment Market

Johnson & Johnson
Pfizer Inc.
Celgene Corporation
Ambit Biosciences Corporation
Cyclacel Pharmaceuticals Inc.
Novartis AG and Sanofi
Bristol Myers Squibb

Segmentation of Global Acute Myeloid Leukemia Treatment Market

The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.

Regional Analysis of Acute Myeloid Leukemia Treatment Market

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

The report for Global Acute myeloid leukemia treatment Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Lithotripsy Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

Market Scenario:

Lithotripsy is medical procedure that break kidney stones in small pieces. It use shock wave to break kidney stones so that it can travel through urinary track and remove from the body. Changing technology and innovation are major driving forces for the global lithotripsy market. Increasing adoption of new products and rising demand for advanced medical instruments are key factors for market growth. Major manufactures are increasing funding for new product development that leading to innovation and increasing competition in this market. Increasing burden of kidney stone is major factor for market growth.

The Global Lithotripsy market is growing at the CAGR of ~4.1% during the forecast period and expected to reach US$ 524.9 million by 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3200

Segments:

Global Lithotripsy Market has been segmented on the basis of type Extracorporeal shock wave lithotripsy (ESWL), Intracorporeal (endoscopic lithotripsy), Percutaneous lithotripsy, and others. Intracorporeal is further sub segmented into Laser lithotripsy, electrohydraulic lithotripsy, Mechanical lithotripsy, and Ultrasonic lithotripsy. On the basis of end user market is segmented into Hospitals and clinics, Research laboratories, Academic Institutes, and others.

Regional Analysis of Global Lithotripsy Market:

Considering the global scenario of the market, Americas holds the largest market share for the global lithotripsy market. In Americas, U.S. accounts the largest market share due to the high adoption of the advanced technology by healthcare professionals and high demand for advanced medical instruments. European is second largest region in global lithotripsy market where Western European countries accounts the largest share of this region. On the other hand, Asia-Pacific (APAC) is fastest growing market and expected to dominate the market by 2023. Middle East and Africa (ME&A) is likely to have a restricted growth in the market due to less awareness of devices and treatment.

Key Players for Global Lithotripsy Market:

Some of the key players in this market are: Boston Scientific (US), DIREX, S.L. (Spain), Dornier MedTech.(Germany), EDAP TMS (France), Elmed Electronics & Medical Industry & Trade Inc.(Turkey), Jena Med Tech GmbH (Germany), Medispec LTD (US), Olympus Corporation (Japan), Siemens Healthcare GmbH (Germany), STORZ MEDICAL AG (Switzerland)

The report for Global Lithotripsy Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/lithotripsy-market-3200

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Research report covers the mHealth Applications Market share and Growth, 2020-2027

Market Scenario:

mHealth is one of the most innovative and disruptive trends in healthcare sector that is growing at prodigious rate from last few years. mHealth is changing the way of traditional medical practices and creating path for the future of healthcare. mHealth assists to check and maintain the health related activity by using technology such as Bluetooth, mobile network (GSM/GPRS/3G/4G), and Wi-Fi. The data collected by mHealth devices such as mobile phones, tablets, laptops and tablet PCs assist to medical professional, consumers, and other users.

Considering the global scenario of the mHealth applications market, the total market for mHealth application was US$ XX billion in 2016 and expected to reach US$ 100.2 billion by 2023. While considering the segments, monitoring application is holding largest market share that is about 53.8% in 2016.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3195

Key Players for Global mHealth Applications Market:

Some of the key players in this market are: Allscripts (US), Agamatrix, Inc. (US), Apple Inc. (US), Honeywell International Inc. (US), Medtronic MiniMed, Inc. (US), Vivify Health (US) and iHealth Labs Inc. (US).

Segments:

Global MHealth applications Market has been segmented on the basis of type which comprise Monitoring Applications, Diagnosis & Treatment, Education & Awareness, Healthcare Management, Wellness & Prevention, and others.

Research Methodology:

Regional Analysis of Global mHealth applications Market:

Considering the global scenario of the market, Europe was holding largest market share of 31.7% in global mHealth applications market in 2016. Asia-Pacific is second largest and fastest growing market in global mHealth applications market. APAC is expected to grow at a CAGR of 33.7% during 2017-2023. North America is one of pioneer in mhealth and is slightly behind the APAC. North America is expected to reach USD 28762.1 million by 2023. On the other hand. Middle East and Africa (ME&A) mHealth was valued USD 1334.9 in 2016 and is expected to grow at steady pace during the forecast period.

The report for Global mHealth Applications Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mhealth-applications-market-3195

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com